课题基金 / 基金详情

Brainstem as an early site in AD and FTLD: closing the etiopathogenic gap

Brainstem as an early site in AD and FTLD: closing the etiopathogenic gap
脑干作为 AD 和 FTLD 的早期部位:缩小病因差距
批准号:
8245592
负责人:
Lea Tenenholz Grinberg
金额:
$45.26万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-30 至 2016-07-31

项目摘要

项目成果

Lea Tenenholz Grinberg的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Features shared by all neurodegenerative diseases represent critical research targets. All follow a characteristic, anatomical sequence, with lesions that spread along functional neuronal network pathways. Despite these commonalities, each disease features a distinct anatomical pattern of early regional vulnerability. These disease-specific anatomical patterns guide translational research by focusing attention on the most relevant targets in humans and model organisms and emphasize the need to identify which brain areas degenerate first in each disease. Strong evidences suggest that specific brainstem (BS) nuclei develop neurofibrillary changes before the cortex in AD. In FTLD, early reports suggest BS neurodegeneration, but few studies have addressed this issue using TDP-43. This information may prove relevant for deciphering early regional vulnerability, anatomical progression and possible non- cognitive symptomatology. Our long-term goal is to provide an integrated picture of BS vulnerability in AD and FTLD-TDP and to incorporate this understanding into the etiopathogenesis of these diseases. The overall objective of this application is to identify the BS histopathological and cytoarchitectonic changes in AD and FTLD-TDP by using a comprehensive network-based approach in well characterized human brains. We will study how often and early these nuclei are involved, whether the changes are symmetric and have a topographical gradient, and which clinical manifestations are associated. This proposal is based on the hypothesis that selected BS nuclei are interdependently and constantly involved in very early stages of AD and FTLD-TDP. Clarifying BS involvement in these diseases will facilitate development of biomarkers, improve diagnostic clinical criteria, and suggest therapeutic targets. The hypothesis will be tested by pursuing two specific aims: To determine the chronology, severity, interdependence, and symptom-relevance of neuropathological changes in the isodendritic core in AD vs. healthy elderly controls and in FTLD vs. healthy elderly controls. This approach is innovative because it utilizes brains processed into thick histological slides and 3D reconstructed. This method is superior in quality, quicker and more economical than the traditional methods and renders excellent stereological and immunohistochemical studies. In addition, the control groups will be composed of a large number of difficult-to-get healthy elderly. This proposal is significant because it is expected to that the knowledge gained will highlight unrecognized early symptoms and suggest new biomarkers and potential therapies. Integrative histopathological and cytoarchitectonic studies remain critical to understanding AD and FTLD and will serve as a foundation for ongoing and future translational research. PUBLIC HEALTH RELEVANCE: The proposed research is relevant to public heath because the high economic and social costs associated with neurodegenerative dementias may soon become an unbearable burden to society and effective disease- modifying treatments remain elusive. For this reason, closing important gaps in the understanding of dementia etiopathogenesis as proposed in this proposal by clarifying the involvement of BS nuclei in AD and FTLD-TDP and proposing novel targets for prevention and treatment of these devastating diseases are relevant to the NIH's mission of reducing burdens of illness and disability.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Imaging brain iron and protein aggregation with MRI for assessing Alzheimer's disease pathology and progression
  • 批准号:
    10563181
  • 项目类别:
  • 资助金额:
    $65.22万
  • 财政年份:
    2021
  • 负责人:
    Lea Tenenholz Grinberg
  • 依托单位:
Imaging brain iron and protein aggregation with MRI for assessing Alzheimer's disease pathology and progression
  • 批准号:
    10331335
  • 项目类别:
  • 资助金额:
    $66.71万
  • 财政年份:
    2021
  • 负责人:
    Lea Tenenholz Grinberg
  • 依托单位:
Core C: Human Tissue Validation
Better memory with literacy acquisition later in life: a randomized controlled trial
海外基金